Literature DB >> 9631804

Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis.

A Kobayashi1, S Hashimoto, K Kooguchi, Y Kitamura, H Onodera, Y Urata, T Ashihara.   

Abstract

STUDY
OBJECTIVE: The objective of this study was to evaluate the role of inducible nitric oxide synthase (iNOS) and proinflammatory cytokines in alveolar macrophages (AMs) in the pathogenesis of ARDS following sepsis.
SETTING: ICU in a university hospital.
DESIGN: Prospective exploratory, open-labeled study was carried out. PATIENTS: A total of 24 patients were investigated: 8 patients diagnosed as having ARDS following sepsis (ARDS group); 8 patients under general anesthesia in the operating room whose lung functions were normal (control group); and 8 patients who were intubated and artificially ventilated for 1 week in the ICU whose lung functions were not deteriorated without fulfilling the ARDS criteria and whose general state fulfilled the sepsis criteria (long-term ventilation group, or LTV group). MEASUREMENTS AND
RESULTS: The expression of iNOS, interleukin-1beta (IL-1beta), interleukin-6 (IL-6), and interleukin-8 (IL-8) in AMs obtained from BAL fluid (BALF) was determined by the immunofluorescent technique. We observed the significant expression of iNOS, IL-6, and IL-8 only in the ARDS group. Meanwhile, NOx (the sum of NO2- + NO3-) was elevated in the BALF supernatant, and IL-6 and IL-8 levels in both the BALF supernatant and the serum were also elevated in the ARDS group. No significant expressions were detected in the control and the LTV group.
CONCLUSIONS: The result that iNOS was detected only in ARDS patients following sepsis suggests that iNOS together with proinflammatory cytokines produced by AMs might play a pivotal role in the pathogenesis of acute lung injury and be useful for monitoring disorders in the lung in such conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631804     DOI: 10.1378/chest.113.6.1632

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

1.  Imaging pulmonary inducible nitric oxide synthase expression with PET.

Authors:  Howard J Huang; Warren Isakow; Derek E Byers; Jacquelyn T Engle; Elizabeth A Griffin; Debra Kemp; Steven L Brody; Robert J Gropler; J Philip Miller; Wenhua Chu; Dong Zhou; Richard A Pierce; Mario Castro; Robert H Mach; Delphine L Chen
Journal:  J Nucl Med       Date:  2014-12-18       Impact factor: 10.057

2.  Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome.

Authors:  Fumiyuki Takahashi; Kazuhisa Takahashi; Kazue Shimizu; Ri Cui; Norihiro Tada; Hideki Takahashi; Sanae Soma; Masakata Yoshioka; Yoshinosuke Fukuchi
Journal:  Lung       Date:  2004       Impact factor: 2.584

3.  Reactive species and pulmonary edema.

Authors:  Karen E Iles; Weifeng Song; David W Miller; Dale A Dickinson; Sadis Matalon
Journal:  Expert Rev Respir Med       Date:  2009-10-01       Impact factor: 3.772

4.  The multiple organ dysfunction syndrome and late-phase mortality in sepsis.

Authors:  Joshua A Englert; Mitchell P Fink
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

5.  Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.

Authors:  M Profita; G Chiappara; F Mirabella; R Di Giorgi; L Chimenti; G Costanzo; L Riccobono; V Bellia; J Bousquet; A M Vignola
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

6.  Role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries.

Authors:  S Muzaffar; J Y Jeremy; G D Angelini; K Stuart-Smith; N Shukla
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

7.  Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling.

Authors:  Yang Li; Gefu Chi; Bingyu Shen; Ye Tian; Haihua Feng
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

8.  Acute pulmonary capillary leak syndrome during elective surgery under general anesthesia.

Authors:  Susumu Ohmi; Tetsuhiro Takei; Kenichiro Habuka; Yoshihiko Watanabe
Journal:  J Anesth       Date:  2008-02-27       Impact factor: 2.078

9.  Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19.

Authors:  Resat Cinar; Malliga R Iyer; George Kunos
Journal:  Br J Pharmacol       Date:  2021-04-17       Impact factor: 9.473

10.  Intratracheal IL-6 protects against lung inflammation in direct, but not indirect, causes of acute lung injury in mice.

Authors:  Rhea Bhargava; William Janssen; Christopher Altmann; Ana Andrés-Hernando; Kayo Okamura; R William Vandivier; Nilesh Ahuja; Sarah Faubel
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.